+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Emerging of dual AIDS associated neoplastic diseases in the era of highly active antiretroviral therapy



Emerging of dual AIDS associated neoplastic diseases in the era of highly active antiretroviral therapy



Sexually Transmitted Infections 79(4): 345-346




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048943427

Download citation: RISBibTeXText

PMID: 12902596

DOI: 10.1136/sti.79.4.345-a


Related references

Three to seven concurrent AIDS-defining disorders at first hospitalization of AIDS presenters as an unexpected emerging feature during the era of highly active antiretroviral therapy. Aids 16(17): 2356-2358, 2002

AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist 10(6): 412-426, 2005

AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy era: emerging management problems. International Journal of Antimicrobial Agents 22(4): 449-452, 2003

Different pattern of AIDS-defining diseases in persons responding to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 26(4): 394-395, 2001

Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet 357(9254): 432-435, 2001

Features of AIDS and AIDS defining diseases during the highly active antiretroviral therapy (HAART) era, compared with the pre-HAART period: a case-control study. Sexually Transmitted Infections 76(2): 145-B-146, 2000

Dual Candida albicans and Cryptococcus neoformans fungaemia in an AIDS presenter: a unique disease association in the highly active antiretroviral therapy (HAART) era. Journal of Medical Microbiology 51(12): 1135-1137, 2002

Incidence of sexually transmitted diseases and HIV infection related to perceived HIV/AIDS threat since highly active antiretroviral therapy availability in men who have sex with men. Sexually Transmitted Diseases 32(3): 170-175, 2005

Lack of change in the distribution of AIDS-defining opportunistic diseases and the related degree of immunodeficiency during the periods before and after the introduction of highly active antiretroviral therapy. European Journal of Clinical Microbiology & Infectious Diseases 20(6): 410-413, 2001

A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. Journal of Acquired Immune Deficiency Syndromes 60(2): 150-157, 2012

Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy. Journal of Clinical Microbiology 37(3): 724-728, 1999

The prevalence of antiretroviral multidrug resistance in highly active antiretroviral therapy-treated patients with HIV/AIDS between 2004 and 2009 in South Korea. Journal of Clinical Virology 60(2): 154-160, 2014

The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. American Journal of Epidemiology 165(10): 1143-1153, 2007

Comparison of metabolic abnormalities 48 weeks after switching from highly active antiretroviral therapy containing a non-nucleoside reverse transcriptase inhibitor to Trizivir versus continued highly active antiretroviral therapy. Aids 17(12): 1855-1856, 2003

Mortality in Brazilian children with HIV/AIDS: the role of non-AIDS-related conditions after highly active antiretroviral therapy introduction. Aids Patient Care and Stds 25(12): 713-718, 2011